In the meantime, it was discovered that RAPA increased the quantity of CD4+CD25+Foxp3+T cells and CD8+ memory T cells in the peripheral blood, preventing CD4+ and DN T cells from producing IL‐4 and IL‐17, which helped active SLE patients experience a reduction in their condition [72]. This evidence concerns the gene CD8A and systemic lupus erythematosus.